4.7 Article

Recurrent Granulibacter bethesdensis Infections and Chronic Granulomatous Disease

Journal

EMERGING INFECTIOUS DISEASES
Volume 16, Issue 9, Pages 1341-1348

Publisher

CENTERS DISEASE CONTROL
DOI: 10.3201/eid1609.091800

Keywords

-

Funding

  1. Baxter Healthcare
  2. CSL Behring
  3. Talecris Biotherapeutics
  4. Nabi Biopharmaceuticals
  5. Prodesse (Gen-Probe)
  6. National Institute of Allergy and Infectious Diseases, NIH

Ask authors/readers for more resources

Chronic granulomatous disease (CGD)is characterized by frequent infections, most of which are curable. Granulibacter bethesdensis is an emerging pathogen in patients with CGD that causes fever and necrotizing lymphadenitis. However, unlike typical CGD organisms, this organism can cause relapse after clinical quiescence. To better define whether infections were newly acquired or recrudesced, we use comparative bacterial genomic hybridization to characterize 11 isolates obtained from 5 patients with CGD from North and Central America. Genomic typing showed that 3 patients had recurrent infection months to years after apparent clinical cure. Two patients were infected with the same strain as previously isolated, and 1 was infected with a genetically distinct strain. This organism is multidrug resistant, and therapy required surgery and combination antimicrobial drugs, including long-term ceftriaxone. G. bethesdensis causes necrotizing lymphadenitis in COD, which may recur or relapse.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available